Evaluation of hematological parameters in migraine attack in emergency room
Evaluation of hematological parameters in migraine attack in emergency room
Aim: Migraine headaches are one of the serious complaints of patients seeking emergency department (ED) with symptoms of manyhealth problems. In this study, we aimed to examine predictive values of hematological parameters on chronic migraine.Material and Methods: The files of patients admitted to ED of Ufuk University Hospital between January 2016 and November 2016with a headache and who underwent hematological analyses at emergency admission were analyzed retrospectively. After exclusioncriteria were applied, 55 patients with migraine attacks who were previously diagnosed with migraine by a neurologist included inthis study.Results: There was not a statistically significant difference between age and sex distribution of groups (p>0.05), whereas astatistically significant difference was found for family history between patient and control groups (p
___
- 1. Friedman D, Feldon S, Holloway R, et al. Utilization, diagnosis,
treatment and cost of migraine treatment in the emergency
department. Headache 2009;49:1163-73.
- 2. (Malone CD, Bhowmick A, Wachholtz AB. Migraine:
treatments, comorbidities, and quality of life, in the USA. J
Pain Res 2015;12:537-47.
- 3. Miller JA, Missmer SA, Vitonis AF, et al. Prevalence of
migraines in adolescents with endometri-osis. Fertil Steril
2018;109:685-90.
- 4. Romero-Reyes M, Uyanik JM. Orofacial pain management:
current perspectives. J Pain Res 2014;21: 99-115.
- 5. Narain S, Al-Khoury L, Chang E. Resolution of chronic
migraine headaches with intrathecal zi-conotide: a case
report. J Pain Res 2015;8:603-6.
- 6. Cerritelli F, Lacorte E, Ruffini N, et al. Osteopathy for
primary headache patients: a systematic review. J Pain Res
2017;14:601-11.
- 7. Davis JA, Robinson RL, Le TK, et al. Incidence and impact
of pain conditions and comorbid illnesses. J Pain Res
2011;4:331-45.
- 8. Negro A, Koverech A, Martelletti P. Serotonin receptor
agonists in the acute treatment of mi-graine: a review on
their therapeutic potential. J Pain Res 2018;8:515-26.
- 9. Vandenbussche N, Laterza D, Lisicki M, et al. Medicationoveruse
headache: a widely recog-nized entity amidst
ongoing debate. J Headache Pain 2018;13:50.
- 10. Peng X, Sun P, Novick D, et al. Real-world comparison of
health care utilization between duloxe-tine and pregabalin
initiators with fibromyalgia. J Pain Res 2014;9:37-46.
- 11. Aamodt AH, Borch-Iohnsen B, Hagen K, et al. Headache
prevalence related to Haemoglobin and ferritin. The HUNT
Study. Cephalalgia 2004;24:758-62.
- 12. Headache Classification Committee of the International
Headache S. The International Classifi-cation of Headache
Disorders, 3rd edition (beta version). Cephalalgia
2013;33:629-808.
- 13. Coenders A, Chapman C, Hannaford P, et al. In search of
risk factors for chronic pain in adoles-cents: a case-control
study of childhood and parental associations. J Pain Res
2014;7:175-83.
- 14. Zencirci B. Comparison of the effects of dietary factors in
the management and prophylaxis of migraine. J Pain Res
2010;23:125-30.
- 15. Stanzani Maserati M. Migraine attacks, aura, and
polycythemia: a vasculoneural pathogenesis? J Neural
Transm (Vienna) 2011;118:545-7.
- 16. Lippi G, Cervellin G, Mattiuzzi C. Migraine and erythrocyte
biology: a review. Int J Lab Hematol 2014;36:591-7.